NEW YORK—Paul Oestreicher, a veteran of corporate and agency healthcare public relations positions, has joined De Vries Public Relations to lead its healthcare practice. He is the second major new hire at De Vries in as many months, following the appointment in June of former advertising agency executive Jim Allman as president.
Oestreicher has helped launch or reposition 40 healthcare products, including a diverse array of pharmaceuticals, consumer health products, diagnostic and medical devices. In addition, he has experience in corporate and crisis communications. Immediately prior to joining DeVries, he served as vice president of communications at Sanofi-Synthelabo.
“Paul has an industry-leading track record of providing counsel, guiding and positioning companies and products, and is one of the pioneers of direct to patient communications,” said agency founder and CEO Madeline DeVries.
Oestreicher started his career as a scientist in the Gastrointestinal Pharmacology group at Wyeth Laboratories and then went to work for Hoffmann-La Roche as clinical project coordinator in the clinical research and development department. At Roche, he gravitated to the “business of science” and had roles of increasing responsibility in the public policy and communications group.
Oestreicher moved to the agency side as senior vice president at Medicus PR in New York and then as general manager of Edelman Healthcare in Chicago. He then joined Genaissance Pharmaceuticals as vice president of strategic marketing and communications.
“I’ve been impressed by the ability of DeVries to leverage its phenomenal consumer and media expertise in the healthcare space,” said Dr. Oestreicher. “By combining both style and substance, DeVries has demonstrated that successful, differentiated healthcare communications are both an art and a science.”